Department of Public Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, Republic of Korea.
Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Sci Rep. 2021 Jun 18;11(1):12886. doi: 10.1038/s41598-021-92362-1.
Machine learning (ML) has been suggested to improve the performance of prediction models. Nevertheless, research on predicting the risk in patients with acute myocardial infarction (AMI) has been limited and showed inconsistency in the performance of ML models versus traditional models (TMs). This study developed ML-based models (logistic regression with regularization, random forest, support vector machine, and extreme gradient boosting) and compared their performance in predicting the short- and long-term mortality of patients with AMI with those of TMs with comparable predictors. The endpoints were the in-hospital mortality of 14,183 participants and the three- and 12-month mortality in patients who survived at discharge. The performance of the ML models in predicting the mortality of patients with an ST-segment elevation myocardial infarction (STEMI) was comparable to the TMs. In contrast, the areas under the curves (AUC) of the ML models for non-STEMI (NSTEMI) in predicting the in-hospital, 3-month, and 12-month mortality were 0.889, 0.849, and 0.860, respectively, which were superior to the TMs, which had corresponding AUCs of 0.873, 0.795, and 0.808. Overall, the performance of the predictive model could be improved, particularly for long-term mortality in NSTEMI, from the ML algorithm rather than using more clinical predictors.
机器学习(ML)被认为可以提高预测模型的性能。然而,用于预测急性心肌梗死(AMI)患者风险的研究有限,并且 ML 模型与传统模型(TMs)的性能不一致。本研究开发了基于 ML 的模型(正则化逻辑回归、随机森林、支持向量机和极端梯度增强),并将其预测 AMI 患者短期和长期死亡率的性能与具有可比预测因子的 TMs 进行了比较。终点是 14183 名参与者的院内死亡率以及出院时存活患者的 3 个月和 12 个月死亡率。ML 模型在预测 ST 段抬高型心肌梗死(STEMI)患者死亡率方面的性能与 TMs 相当。相比之下,ML 模型对非 ST 段抬高型心肌梗死(NSTEMI)患者的院内、3 个月和 12 个月死亡率的预测的曲线下面积(AUC)分别为 0.889、0.849 和 0.860,优于 AUC 分别为 0.873、0.795 和 0.808 的 TMs。总体而言,预测模型的性能可以得到改善,特别是对于 NSTEMI 的长期死亡率,可以通过 ML 算法而不是使用更多的临床预测因子来实现。